keto with glp 1 and semaglutide: the complete guide to combining them safely I'm On A GLP-1--Is Keto

The dual mechanism appears to produce greater appetite suppression and metabolic improvement than single-agonist therapy alone, though the precise contribution of each pathway remains an active area of research

However, relevant research on their roles in breast cancer and the regulatory mechanisms are still lacking and needs to be supplemented

Williams, N., & Weir, T

Park PJ, Cho EG

2025;166(4):bqaf028

The Pivotal Cohort is fully randomized and well powered at the expected effect size to clear both co-primary endpoints in the modified intention-to-treat (mITT) population: (i) weight regain at six months (Revita versus sham) and (ii) a responder rate defined as the proportion of participants maintaining at least 5% total body weight loss relative to their pre-tirzepatide weight at one year